United States Quest Tender

Ro the healthcare technology company and Quest Diagnostics the nations leader in diagnostic information services announced a strategic partnership to add diagnostic capabilities and lab testing to Ros vertically integrated primary care platform. The partnership will support Ros expansion in the treatment and management of chronic and complex medical conditions facilitated on its platform.Quest Diagnostics is the first diagnostic services provider to collaborate with Ro to help patients manage chronic conditions through virtual and in-home care. As the leading provider of diagnostic information services Quest provides thousands of laboratory screening and diagnostic test services and operates 2200 patient service centers where individuals can provide lab samples across the United States.This partnership complements Ros recent acquisition of Workpath a software platform that enables on-demand in-home care. The acquisition allows Ro to seamlessly integrate virtual and in-person care and send healthcare professionals to a patients home for blood draws vaccinations and more. All diagnostic tests for Ro patients will be processed by Quest Diagnostics and patients will be able to have blood draws performed in their home through Ros integration with Workpath or at a Quest Diagnostics facility.Initial Quest Diagnostics services offered through Ro will focus on hormone testing including total testosterone and PSA. The addition of diagnostic testing services is expected to dramatically expand the range of services Ro can provide for example treatment for hypothyroidism STIs diabetes and hyperlipidemia. Seventy percent of medical decisions are based on lab results and many patients need ongoing diagnostic data and provider guidance to manage their conditions said Melynda Barnes MD SVP of Medical Affairs and Research of Ro. This partnership permits physicians and patients on Ros platform to have access to these critical diagnostic services allowing for the treatment of increasingly complex conditions through Ro and encourages ongoing patient-provider engagement.At Quest Diagnostics we recognize that healthcare is becoming more and more consumer-driven said Cathy Doherty senior vice president and group executive clinical franchise solutions and marketing Quest Diagnostics. Ro has created a virtual care model that does what any good healthcare provider does but few health technology companies do well foster intimacy and trust with each patient. Through our industry-first relationship Quest will add quality diagnostic insights to the proven Ro model so more people can access care for a broader array of medical conditions when and where they need it most. Ro patients will be able to access and discuss their lab results and treatment plan with their provider at any time. With this partnership Ro seamlessly connects a patients doctor pharmacy and diagnostics facilitating end-to-end care from diagnosis to the delivery of medication to ongoing care.